Answers are grounded in this paper and cite their sources.
Low serum 25-hydroxyvitamin D [25(OH)D] is common in herpes zoster (HZ), but its immune significance remains uncertain. We combined retrospective clinical analysis, Mendelian randomization (MR), and longitudinal blood transcriptomics. Among 67 hospitalized adults with HZ and 23 controls, adjusted serum 25(OH)D was 6.94 ng/mL lower in HZ (95% CI, −10.29 to −3.58; P < 0.001), without a clear association with admission pain. Two FinnGen R13 MR outcomes gave near-null estimates for genetically predicted long-term 25(OH)D and HZ susceptibility. In an independent HZ cohort, IFN-α and IFN-γ responses were significantly positively enriched during active disease relative to recovery. Genes induced by a short-term human vitamin D intervention showed weak negative enrichment in HZ (normalized enrichment score [NES] = −1.313; false discovery rate (FDR) = 0.052), while vitamin D-suppressed genes also showed strong negative enrichment (NES = −3.256; FDR < 0.001), contrary to the expected positive direction. This persisted after composition adjustment. Thus, acute HZ transcriptional changes were not a simple reversal of short-term vitamin D responses. Low inpatient 25(OH)D alone does not establish that vitamin D insufficiency drives acute immune changes in HZ.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: